Sensex
72,781.89 profit arw -251.89 (-0.34%)
Nifty
22,622.70 profit arw -99.25 (-0.44%)
Nasdaq
18,355.20 profit arw -497.09 (-2.64%)
logo img

GET IN TOUCH

GET IN TOUCH

Enter a 10 digit mobile number starting with 7, 8, or 9
Captcha verification code, enter the characters shown below

As on : 12-Oct-2026
Corporate News
12-Oct-2026     20:47

Goldline Pharmaceutical submitted a certificate to the Bombay Stock Exchange regarding share holdings

Goldline Pharmaceutical Limited submitted a certificate to the Bombay Stock Exchange under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter and half year ended September 30, 2026, received from Bigshare Services Private Limited, its Registrar and Share Transfer Agent. Separately, Bigshare Services Private Limited confirmed that the same regulation is not applicable to Goldline Pharmaceutical Limited for the quarter ended September 30, 2026, as the company’s shares are held in demat form and no requests for dematerialization were received.

INDIAN INDICES

Sensex

72,781.89 -251.89 (-0.34%)

Nifty

22,622.70 -99.25 (-0.44%)

GLOBAL INDICES

USD

NA

NASDAQ
HANG SENG

24,307.67 -37.55(-0.15%)